2012
DOI: 10.1016/s0735-1097(12)60449-5
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical and Molecular Characteristics of Coronary Thrombus Resistant to Fibrinolysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…12,21 Such studies, when performed in patients with acute coronary syndromesin vivo, are scarce in the literature. 13 In a recent study, which highlighted the potential practical applicability of a greater knowledge of thrombus structure, Sambola et al 15 assessed the thrombotic burden in aspirates from ten patients undergoing PPCI, compared to ten patients undergoing rescue PCI after ineffective response to tenecteplase. A higher concentration of neutrophils was also identified in the plaques of unstable patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…12,21 Such studies, when performed in patients with acute coronary syndromesin vivo, are scarce in the literature. 13 In a recent study, which highlighted the potential practical applicability of a greater knowledge of thrombus structure, Sambola et al 15 assessed the thrombotic burden in aspirates from ten patients undergoing PPCI, compared to ten patients undergoing rescue PCI after ineffective response to tenecteplase. A higher concentration of neutrophils was also identified in the plaques of unstable patients.…”
Section: Discussionmentioning
confidence: 99%
“…[12][13][14][15] In the scenario of STEMI, few studies have evaluated the immunohistochemical profile of intracoronary thrombus in vivo and its correlation with clinical variables. The expression of the endothelial cell activity, of platelet function, of and coagulation cascade activation can be estimated by the immunohistochemical expression of the antigens CD34, CD61, and factor VIII, respectively.…”
mentioning
confidence: 99%